Armis Biopharma, Inc.

Armis Biopharma is a Colorado-based biopharmaceutical company developing the Veriox® antimicrobial platform—a patented peracid/hydrogen peroxide-based technology for wound healing, disinfection, and decontamination. The platform targets antimicrobial-resistant (AMR) pathogens through a novel non-systemic mechanism of action effective against Gram-positive, Gram-negative, viral, and fungal threats, as well as chemical and biological warfare agents. Veriox® delivers high concentrations of active agent with minimal systemic exposure, providing both prophylactic and therapeutic efficacy while reducing hospital, insurer, and patient care costs. Products include ArmiClenz disinfectant and ArmiCare hand sanitizer, designed for infection control in clinical and contamination scenarios.